Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial | Zendy

Jason Madan | Zendy; Laura Roșu | Zendy; Mamo Girma Tefera | Zendy; Craig van Rensburg | Zendy; Denise Evans | Zendy; Ivor Langley | Zendy; Ewan Tomeny | Zendy; Andrew Nunn | Zendy; Patrick Phillips | Zendy; I. D. Rusen | Zendy; S. Bertel Squire | Zendy

Open Access

Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial

Author(s) -

Jason Madan,

Laura Roșu,

Mamo Girma Tefera,

Craig van Rensburg,

Denise Evans,

Ivor Langley,

Ewan Tomeny,

Andrew Nunn,

Patrick Phillips,

I. D. Rusen,

S. Bertel Squire

Publication year - 2020

Publication title -

bulletin of the world health organization

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.459

H-Index - 168

eISSN - 1564-0604

pISSN - 0042-9686

DOI - 10.2471/blt.19.243584

Subject(s) - regimen , medicine , tuberculosis , total cost , randomized controlled trial , health care , cost–benefit analysis , environmental health , surgery , economic growth , business , economics , pathology , accounting , ecology , biology

To investigate cost changes for health systems and participants, resulting from switching to short treatment regimens for multidrug-resistant (MDR) tuberculosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research